about
Comparing reactive oxygen species and DNA fragmentation in semen samples of unexplained infertile and healthy fertile men.Evaluation of the p53 and Thioredoxin reductase in sperm from asthenozoospermic males in comparison to normozoospermic males.mZD7349 peptide-conjugated PLGA nanoparticles directed against VCAM-1 for targeted delivery of simvastatin to restore dysfunctional HUVECs.Survey of the effect of doxorubicin and flavonoid extract of white Morus alba leaf on apoptosis induction in a-172 GBM cell line.Circulating Levels of LAMP2 in Coronary Artery Disease: Association with Serum Lipid Profile.The mRNA Expression and Circulating Levels of Visfatin and Their Correlation with Coronary Artery Disease Severity and 25-Hydroxyvitamin D.Apolipoprotein E genotypes of fertile and infertile men.Lower circulating levels of CTRP12 and CTRP13 in polycystic ovarian syndrome: Irrespective of obesitySerum levels of CTRP3 in diabetic nephropathy and its relationship with insulin resistance and kidney functionGenetic variation of hormone sensitive lipase and male infertilityGenotype and phenotype frequencies of paraoxonase 1 in fertile and infertile menNiemann-Pick Disease, Type C1 Gene Expression in PBMCs is Associated with Interleukin 10 Serum Concentration: a Case-Control StudyCirculating Levels of IL-35 and Gene Expression of FoxP3 in Coronary Artery Disease: Is There Any Interplay Between Them and 25-Hydroxyvitamin D3?Supplementation of sperm freezing medium with myoinositol improve human sperm parameters and protects it against DNA fragmentation and apoptosisEffects of DHA-enriched fish oil on gene expression levels of p53 and NF-κB and PPAR-γ activity in PBMCs of patients with T2DM: A randomized, double-blind, clinical trialDoes myoinositol supplement improve sperm parameters and DNA integrity in patients with oligoasthenoteratozoospermia after the freezing-thawing process?Evaluation of the NOX5 protein expression and oxidative stress in sperm from asthenozoospermic men compared to normozoospermic men
P50
Q46260612-A55DE113-3CAA-42E2-8327-0029E6AA2D81Q47228987-9B1373F5-9762-4C2F-91E8-CE3EC5E5CAA9Q48844538-03C0A785-72C3-4EE3-A444-6C617E277EA9Q49797733-F7780AFF-FA2E-49B1-9025-6FB661AFE0D0Q51025710-BB5788B7-1B56-4965-BF67-5DF7A865AA0FQ53317451-75A84F0C-757E-4111-8FF2-8CA2AA444904Q54311054-0C766172-C11B-4EE3-A959-6647F24A9E35Q60303054-3805B375-6699-4DA5-A27E-B56748AB228EQ64099518-49B62F68-EF00-4D80-9F44-86D37DA1308AQ84947165-FFDD1527-A738-4683-BEAD-379150931457Q85648893-C62ADFB5-9D7F-42B5-9324-90ED022D12CFQ87876504-3498F63F-3F66-4768-ACD1-091D3B951083Q88606011-F01A5BEA-96FA-41D3-A87A-52706AFC31D0Q91265323-55586ECB-A163-473D-8E85-90A5FAAB4071Q91928673-E67EC1DC-9064-4233-BF9E-D096C16B9078Q92032311-BB9C7FCC-1006-4AF4-89B6-14F39FDE8B82Q92960556-756DB5F6-80E1-4084-A2B4-71768551EC0E
P50
description
investigador
@es
researcher
@en
name
Akram Vatannejad
@en
type
label
Akram Vatannejad
@en
prefLabel
Akram Vatannejad
@en
P31
P496
0000-0002-8202-7914